Use of turbidimetric growth curves for early determination of antifungal drug resistance of filamentous fungi

被引:38
作者
Meletiadis, J
te Dorsthorst, DTA
Verweij, PE
机构
[1] Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands
[2] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands
[3] Univ Nijmegen, Ctr Infect Dis, NL-6500 HB Nijmegen, Netherlands
关键词
D O I
10.1128/JCM.41.10.4718-4725.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A previously described microbroth kinetic system (J. Meletiadis, J. F. Meis, J. W. Mouton, and P. E. Verweij, J. Clin. Microbiol. 39:478-484,2001) based on continuous monitoring of changes in the optical density of fungal growth was used to describe turbidimetric growth curves of different filamentous fungi in the presence of increasing concentrations of antifungal drugs. Therefore, 24 clinical mold isolates, including Rhizopus oryzae, Aspergillus fumigatus, Aspergillus flavus, and Scedosporium prolificans, were tested against itraconazole, terbinafine, and amphotericin B according to NCCLS guidelines. Among various parameters of the growth curves, the duration of the lag phase was strongly affected by the presence of antifungal drugs. Exposure to increasing drug concentrations resulted in prolonged lag phases of the turbidimetric growth curves. The lag phases of the growth curves at drug concentrations which resulted in more than 50% growth (for itraconazole and terbinafine) and more than 75% growth (for amphotericin B) after 24 h of incubation for R. oryzae, 48 h for Aspergillus spp., and 72 h for S. prolificans Were 4 h longer than the lag phases of the growth curves at the corresponding drug-free growth controls which varied from 4.4 h for R. oryzae, 6.5 It for A. flavus, 7.9 h for A. fumigatus, and 11.6 h for S. prolificans. The duration of the lag phases showed small experimental and interstrain variability, with differences of less than 2 h in most of the cases. Using this system, itraconazole and terbinafine resistance (presence of >50% growth) as well as amphotericin B resistance (presence of >75% growth) was determined within incubation periods of 5.0 to 7.7 h for R. oryzae (for amphotericin B resistance incubation for up to 12 h was required), 8.8 to 11.4 h for A. fumigatus, 6.7 to 8.5 h for A. flavus, and 13 to 15.6 h for S. prolificans while awaiting formal MIC determination by the NCCLS reference method.
引用
收藏
页码:4718 / 4725
页数:8
相关论文
共 38 条
[11]  
DENNING DW, 1991, REV INFECT DIS, V13, P345
[12]   In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi [J].
Espinel-Ingroff, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (03) :954-958
[13]   SPECTROPHOTOMETRIC METHOD OF INOCULUM PREPARATION FOR THE INVITRO SUSCEPTIBILITY TESTING OF FILAMENTOUS FUNGI [J].
ESPINELINGROFF, A ;
KERKERING, TM .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (02) :393-394
[14]   NEW IN-VITRO ASSAY BASED ON GLUCOSE CONSUMPTION FOR DETERMINING ITRACONAZOLE AND AMPHOTERICIN-B ACTIVITIES AGAINST ASPERGILLUS-FUMIGATUS [J].
GARRIGUES, JC ;
DEFONTENAY, GC ;
LINAS, MD ;
LAGENTE, M ;
SEGUELA, JP .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (12) :2857-2862
[15]   EFFECT OF INCREASING INOCULUM SIZES OF PATHOGENIC FILAMENTOUS FUNGI ON MICS OF ANTIFUNGAL AGENTS BY BROTH MICRODILUTION METHOD [J].
GEHRT, A ;
PETER, J ;
PIZZO, PA ;
WALSH, TJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (05) :1302-1307
[16]   Susceptibility testing of fungi: Current status of correlation of in vitro data with clinical outcome [J].
Ghannoum, MA ;
Rex, JH ;
Galgiani, JN .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (03) :489-495
[17]   Antifungal drug resistance of pathogenic fungi [J].
Kontoyiannis, DP ;
Lewis, RE .
LANCET, 2002, 359 (9312) :1135-1144
[18]   MORPHOLOGICAL EFFECTS OF LIPOPEPTIDES AGAINST ASPERGILLUS-FUMIGATUS CORRELATE WITH ACTIVITIES AGAINST (1,3)-BETA-D-GLUCAN SYNTHASE [J].
KURTZ, MB ;
HEATH, IB ;
MARRINAN, J ;
DREIKORN, S ;
ONISHI, J ;
DOUGLAS, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (07) :1480-1489
[19]   Studies of in vitro activities of voriconazole and itraconazole against Aspergillus hyphae using viability staining [J].
Lass-Flörl, C ;
Nagl, M ;
Speth, C ;
Ulmer, H ;
Dierich, MP ;
Würzner, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) :124-128
[20]   Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients [J].
Marr, KA ;
Carter, RA ;
Crippa, F ;
Wald, A ;
Corey, L .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (07) :909-917